NET PROFIT (x1000 DKK)
EMPLOYEES
Eurofins Genomics Denmark A/S
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
-14,525
|
-26,592
|
-16,474 |
| Total assets |
175,330
|
134,500
|
77,042 |
| Current assets |
122,577
|
87,824
|
44,342 |
| Current liabilities |
75,419
|
56,874
|
20,507 |
| Equity capital |
-4,144
|
17,796
|
15,936 |
| - share capital |
550
|
550
|
550 |
| Employees (average) |
35
|
35
|
35 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
-2.4%
|
13.2%
|
20.7% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
162.5%
|
154.4%
|
216.2% |
| Return on equity (ROE) |
350.5%
|
-149.4%
|
-103.4% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.